Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/1996
10/10/1996WO1996031492A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
10/10/1996WO1996031212A1 A method for the treatment of macular degeneration
10/10/1996CA2216281A1 A method for the treatment of macular degeneration
10/09/1996EP0736032A1 Heterocyclic compounds
10/09/1996EP0736022A1 5-(2-imidazolinylamino)benzimidazole derivatives, their preparation and their use as alpha-2 adrenoceptor agonists
10/09/1996EP0736020A1 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
10/09/1996EP0735895A1 A method for preventing or controlling cataract
10/09/1996EP0735877A1 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists
10/09/1996EP0735868A1 Use of non-steroidal cyclooxygenase inhibitors to treat elevated intraocular pressure
10/09/1996EP0678089B1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders
10/09/1996EP0678088B1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders
10/09/1996EP0647227B1 Purinone antianginal agents
10/09/1996CN1133047A Therapeutic peptide derivatives
10/09/1996CN1132755A Aescinic lactonic derivative, its prep. and medicine composition thereof
10/09/1996CN1132627A Chinese medicinal eyedrops
10/08/1996US5563154 Tetrahydro-quinolinyl/isoquinolinyl-terminal alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
10/08/1996US5563143 Antiinflammatory agents, autoimmune disorders
10/08/1996US5562908 Treatment of sinus headache
10/03/1996WO1996030403A1 Methods of treating disorders of the eye
10/03/1996WO1996030343A1 Inhibitors of farnesyl-protein transferase
10/03/1996WO1996030046A1 Vascular endothelial cell growth factor antagonists
10/03/1996WO1996029984A1 Sterile ophthalmological gel preparation applicable in drops and process for producing it
10/03/1996WO1996029974A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/03/1996CA2805588A1 Vascular endothelial cell growth factor antagonists
10/03/1996CA2754887A1 Vascular endothelial cell growth factor antagonists
10/03/1996CA2216707A1 Inhibitors of farnesyl-protein transferase
10/03/1996CA2216651A1 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/03/1996CA2215330A1 Methods of treating disorders of the eye
10/02/1996EP0734730A1 Use of a CGRP antagonist for the treatment of ocular or eyelid pruritis and disesthesies
10/02/1996EP0734396A1 ANALOGUES OF hGH-RH (1-29)NH 2? HAVING ANTAGONISTIC ACTIVITY
10/02/1996EP0734261A1 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
10/02/1996EP0734248A1 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
10/02/1996EP0645056B1 Micromechanical thermoelectric sensor element
10/02/1996DE19511322A1 Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung Sterile ophthalmic gels containing medium chain triglycerides and processes for their preparation
10/02/1996CN1132475A Composion for releasing essence for nose
10/01/1996US5561163 Treating hearing loss with deprenyl
10/01/1996US5561132 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
09/1996
09/26/1996WO1996029411A1 Protein production and delivery
09/26/1996WO1996029332A1 Process for isolating galanthamine
09/26/1996WO1996029315A2 Imidazole derivatives as histamine receptor h3 (ant)agonists
09/26/1996WO1996023065A3 Inhibition of neovascularization using vegf-specific oligonucleotides
09/26/1996CA2215618A1 Protein production and delivery
09/26/1996CA2190865A1 Imidazole derivatives as histamine receptor h3 (ant)agonists
09/25/1996EP0733066A1 Pretargeting methods and compounds
09/25/1996EP0732913A1 Synthetic viscoelastic material for ophthalmic application
09/24/1996US5559157 Acetate, nicotinate or succinate, sorbic acid preservative
09/24/1996US5559151 Method for reducing intraocular pressure in the mammalian eye by administration of chloride channel blockers
09/24/1996US5559138 Method of Treating Glaucoma Using Oxadiazolyl or Thiadiazolyl Tetrahydropyridines
09/24/1996US5559136 Treatment of Alzheimer's disease using azacyclic compounds
09/24/1996US5559111 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides
09/24/1996US5559104 Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use
09/19/1996WO1996028161A1 Use of a 2-(4-(azolylbutyl)-piperazinyl-methyl)-benzimidazole derivative for treating allergic conjunctivitis
09/19/1996DE19509663A1 Verfahren zur Isolierung von Galanthamin A method for the isolation of galanthamine
09/19/1996CA2190187A1 Use of a 2-(4-(azolylbutyl)-piperazinyl-methyl)-benzimidazole derivative for treating allergic conjunctivitis
09/18/1996EP0732328A1 Aromatic heterocyclic compounds, pharmaceutical and cosmetic compositions containing them and their uses
09/18/1996EP0731839A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition
09/18/1996EP0731787A1 Crystalline, polymorphic form of (s,s,s)-n-(1- 2-carboxy-3-(n?2 -mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine
09/18/1996EP0731696A1 Cysteine protease inhibitors containing heterocyclic leaving groups
09/18/1996CN1131150A 3-phenyl isoquinolin-1(2H)-one derivant, its preparation method and medicinal use thereof
09/18/1996CN1131030A Injection for curing edematous conjunctivitis of piglet
09/17/1996US5556981 Angiotensin II antagonist intermediates
09/17/1996US5556753 DNA encoding human α1 adrenegric receptors and uses thereof
09/12/1996WO1996027593A1 Arginine analogues having nitric oxide synthase inhibitor activity
09/11/1996EP0730590A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
09/11/1996EP0730443A1 Suspension of loteprednol etabonate
09/11/1996CN1130866A Anti-angiogenic compositions and method of use
09/11/1996CN1130518A Jiuweimingmuzhujing powder for improving eyesight
09/11/1996CN1032750C Process for prepn. of ureido derivatives of poly 4-amino-2-carboxy-1-methyl compounds
09/10/1996US5554625 Substituted biphenylmethylimidazopyridines
09/10/1996US5554624 Imidazopyridine derivatives as angiotensin II antagonists
09/10/1996US5554367 Compositions for treatment of glaucoma
09/06/1996WO1996027006A2 Human vegf-specific antisense oligonucleotides
09/06/1996WO1996016981A3 Peptide compounds for prevention and/or treatment of no-mediated diseases
09/06/1996WO1996016647A3 Use of chloride channel blockers for reducing intraocular pressure
09/04/1996CN1130354A Compositions containing amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of decongestant an expectorant, an antihistamine and an antitussive
09/03/1996US5552520 Such as somatostatin analogs or bombesin analogs
09/03/1996US5552434 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these compounds
09/03/1996US5552421 Leukotriene biosynthesis inhibitors
09/03/1996US5552403 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
08/1996
08/29/1996WO1996025936A1 2,6-diaryl pyridazinones with immunosuppressant activity
08/29/1996CA2213135A1 2,6-diaryl pyridazinones with immunosuppressant activity
08/28/1996EP0728746A1 Azepinone compounds useful in the inhibition of ACE and NEP
08/28/1996EP0728739A1 Biaromatic amide derivatives, pharmaceutical and cosmetic compositions containing them and their utilisations
08/28/1996EP0728738A1 Tetralinyl- and indanyl-ethylamides having melatonergic activity
08/28/1996EP0728480A1 Use of ifenprodil for treatment of elevated intraocular pressure
08/28/1996EP0728145A1 Endothelin receptor antagonists
08/28/1996EP0728128A1 Substituted phenyl compounds
08/28/1996EP0728006A1 Use of mannose phosphates for the treatment of fibrotic disorders
08/28/1996EP0727995A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
08/28/1996CN1129702A Imidazopyridines
08/27/1996USRE35321 Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity
08/27/1996US5550212 Analogues of hGH-RH(1-29)NH2 having antagonistic activity
08/27/1996US5550125 Brain disorders
08/27/1996US5550050 Exposing cells enclosed in biocompatible capsules to restrictive environmental conditions which match those which will be encountered after implantation until desired responses are established
08/27/1996CA1338554C Combination of tobramycin and steroids for topical ophthalmic use
08/22/1996WO1996025422A1 Keratinocyte growth factor-2
08/22/1996WO1996025405A1 Substituted isoxazoles for the treatment of inflammation
08/22/1996WO1996025403A1 α-SUBSTITUTED HYDRAZIDES HAVING CALPAIN INHIBITORY ACTIVITY
08/22/1996WO1996025397A1 Indole derivatives with affinity for the cannabinoid receptor
08/22/1996WO1996025171A1 Inhibition of angiogenesis using interleukin-12
1 ... 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 ... 531